• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺神经内分泌肿瘤细胞系BON-1和QGP-1的全面分子特征分析

A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1.

作者信息

Luley Kim B, Biedermann Shauni B, Künstner Axel, Busch Hauke, Franzenburg Sören, Schrader Jörg, Grabowski Patricia, Wellner Ulrich F, Keck Tobias, Brabant Georg, Schmid Sebastian M, Lehnert Hendrik, Ungefroren Hendrik

机构信息

Clinic for Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, D-23538 Lübeck, Germany.

First Department of Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, D-23538 Lübeck, Germany.

出版信息

Cancers (Basel). 2020 Mar 14;12(3):691. doi: 10.3390/cancers12030691.

DOI:10.3390/cancers12030691
PMID:32183367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140066/
Abstract

Experimental models of neuroendocrine tumor disease are scarce, with only a few existing neuroendocrine tumor cell lines of pancreatic origin (panNET). Their molecular characterization has so far focused on the neuroendocrine phenotype and cancer-related mutations, while a transcription-based assessment of their developmental origin and malignant potential is lacking. In this study, we performed immunoblotting and qPCR analysis of neuroendocrine, epithelial, developmental endocrine-related genes as well as next-generation sequencing (NGS) analysis of microRNAs (miRs) on three panNET cell lines, BON-1, QGP-1, and NT-3. All three lines displayed a neuroendocrine and epithelial phenotype; however, while insulinoma-derived NT-3 cells preferentially expressed markers of mature functional pancreatic β-cells (i.e., , ), both BON-1 and QGP-1 displayed high expression of genes associated with immature or non-functional β/δ-cells genes (i.e., ), or pancreatic endocrine progenitors (i.e., ). NGS-based identification of miRs in BON-1 and QGP-1 cells revealed the presence of all six members of the miR-17-92 cluster, which have been implicated in b-cell function and differentiation, but also have roles in cancer being both oncogenic or tumor suppressive. Notably, both BON-1 and QGP-1 cells expressed several miRs known to be negatively associated with epithelial-mesenchymal transition, invasion or metastasis. Moreover, both cell lines failed to exhibit migratory activity in vitro. Taken together, NT-3 cells resemble mature functional β-cells, while both BON-1 and QGP-1 are more similar to immature/non-functional pancreatic β/δ-cells or pancreatic endocrine progenitors. Based on the recent identification of three transcriptional subtypes in panNETs, NT-3 cells resemble the "islet/insulinoma tumors" (IT) subtype, while BON-1 and QGP-1 cells were tentatively classified as "metastasis-like/primary" (MLP). Our results provide a comprehensive characterization of three panNET cell lines and demonstrate their relevance as neuroendocrine tumor models.

摘要

神经内分泌肿瘤疾病的实验模型稀缺,仅存在少数源自胰腺的神经内分泌肿瘤细胞系(胰腺神经内分泌肿瘤,panNET)。到目前为止,它们的分子特征主要集中在神经内分泌表型和癌症相关突变上,而缺乏基于转录的对其发育起源和恶性潜能的评估。在本研究中,我们对三种panNET细胞系BON-1、QGP-1和NT-3进行了神经内分泌、上皮、发育内分泌相关基因的免疫印迹和qPCR分析,以及微小RNA(miR)的下一代测序(NGS)分析。所有这三种细胞系均表现出神经内分泌和上皮表型;然而,虽然源自胰岛素瘤的NT-3细胞优先表达成熟功能性胰腺β细胞的标志物(即 , ),但BON-1和QGP-1均高表达与未成熟或无功能的β/δ细胞基因(即 )或胰腺内分泌祖细胞(即 )相关的基因。基于NGS对BON-1和QGP-1细胞中miR的鉴定揭示了miR-17-92簇的所有六个成员的存在,这些成员与β细胞功能和分化有关,但在癌症中也具有致癌或肿瘤抑制作用。值得注意的是,BON-1和QGP-1细胞均表达了几种已知与上皮-间质转化、侵袭或转移呈负相关的miR。此外,这两种细胞系在体外均未表现出迁移活性。综上所述,NT-3细胞类似于成熟的功能性β细胞,而BON-1和QGP-1更类似于未成熟/无功能的胰腺β/δ细胞或胰腺内分泌祖细胞。基于最近在panNET中鉴定出的三种转录亚型,NT-3细胞类似于“胰岛/胰岛素瘤肿瘤”(IT)亚型,而BON-1和QGP-1细胞被初步归类为“转移样/原发性”(MLP)。我们的结果提供了三种panNET细胞系的全面特征,并证明了它们作为神经内分泌肿瘤模型的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/6353d7a9a168/cancers-12-00691-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/1a600468eb18/cancers-12-00691-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/783c3e50dcc3/cancers-12-00691-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/68f8737eaae0/cancers-12-00691-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/39c2637b0f33/cancers-12-00691-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/d96098dc46d7/cancers-12-00691-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/6353d7a9a168/cancers-12-00691-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/1a600468eb18/cancers-12-00691-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/783c3e50dcc3/cancers-12-00691-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/68f8737eaae0/cancers-12-00691-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/39c2637b0f33/cancers-12-00691-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/d96098dc46d7/cancers-12-00691-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7140066/6353d7a9a168/cancers-12-00691-g006.jpg

相似文献

1
A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1.胰腺神经内分泌肿瘤细胞系BON-1和QGP-1的全面分子特征分析
Cancers (Basel). 2020 Mar 14;12(3):691. doi: 10.3390/cancers12030691.
2
Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.生长抑素、奥曲肽和兰瑞肽对已建立和原代神经内分泌肿瘤细胞系的神经内分泌分化和增殖的差异影响:与 TGF-β 信号的可能串扰。
Int J Mol Sci. 2022 Dec 14;23(24):15868. doi: 10.3390/ijms232415868.
3
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.胰腺神经内分泌肿瘤细胞系BON-1和QGP-1的全外显子特征分析
J Mol Endocrinol. 2015 Apr;54(2):137-47. doi: 10.1530/JME-14-0304. Epub 2015 Jan 22.
4
Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment.成纤维细胞与胰腺神经内分泌肿瘤细胞之间的相互作用:肿瘤微环境的潜在影响
Cancers (Basel). 2022 Jul 18;14(14):3481. doi: 10.3390/cancers14143481.
5
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.建立首例分化良好的人胰腺神经内分泌肿瘤模型。
Mol Cancer Res. 2018 Mar;16(3):496-507. doi: 10.1158/1541-7786.MCR-17-0163. Epub 2018 Jan 12.
6
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.GEPNET 细胞系的神经内分泌表型、基因组特征和治疗敏感性。
Endocr Relat Cancer. 2018 Mar;25(3):367-380. doi: 10.1530/ERC-17-0445.
7
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.选择性PI3Kα抑制剂BYL719作为神经内分泌肿瘤的一种新型治疗选择:来自多个细胞系模型的结果
PLoS One. 2017 Aug 11;12(8):e0182852. doi: 10.1371/journal.pone.0182852. eCollection 2017.
8
Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors.载舒尼替尼的硫酸软骨素水凝胶作为治疗胰腺神经内分泌肿瘤的新型药物递送机制。
Ann Surg Oncol. 2021 Dec;28(13):8532-8543. doi: 10.1245/s10434-021-10245-1. Epub 2021 Jun 5.
9
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.新型PI3K-AKT-mTOR抑制剂可克服胰腺神经内分泌肿瘤长期获得性依维莫司耐药性。
Br J Cancer. 2016 Mar 15;114(6):650-8. doi: 10.1038/bjc.2016.25.
10
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.UCHL1 缺失改变转移性胰腺神经内分泌肿瘤的细胞周期。
Endocr Relat Cancer. 2019 Apr 1;26(4):411-423. doi: 10.1530/ERC-18-0507. Epub 2019 Jan 1.

引用本文的文献

1
Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers.胰腺神经内分泌肿瘤的转录组分析:WNT、MAPK、PI3K、NEDDylation信号通路失调及潜在的非侵入性生物标志物
PLoS One. 2025 Jun 16;20(6):e0325672. doi: 10.1371/journal.pone.0325672. eCollection 2025.
2
Single-cell transcriptome conservation in a multispecies comparative analysis of fresh and cryopreserved insulinoma cell lines.新鲜和冷冻保存的胰岛素瘤细胞系多物种比较分析中的单细胞转录组保守性
Vet Oncol. 2025;2(1):14. doi: 10.1186/s44356-025-00025-4. Epub 2025 May 27.
3

本文引用的文献

1
Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan.Rac1b对高转移性胰腺癌细胞迁移的负调控由非活化Smad3和双糖链蛋白聚糖的顺序诱导介导。
Cancers (Basel). 2019 Dec 6;11(12):1959. doi: 10.3390/cancers11121959.
2
RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.RAC1B:上皮表型的守护者和上皮-间充质转化的抑制剂。
Cells. 2019 Dec 4;8(12):1569. doi: 10.3390/cells8121569.
3
A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis.
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms.
溶瘤性单纯疱疹病毒作为胃肠胰神经内分泌肿瘤潜在治疗剂的研究。
Sci Rep. 2025 Apr 17;15(1):13356. doi: 10.1038/s41598-025-98588-7.
4
Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review.胰腺腺癌和神经内分泌肿瘤中转化生长因子-β与生长抑素信号转导的相互作用:简要综述
Front Endocrinol (Lausanne). 2025 Mar 11;16:1511348. doi: 10.3389/fendo.2025.1511348. eCollection 2025.
5
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.2024年神经内分泌肿瘤模型会议白皮书:神经内分泌肿瘤研究模型的现状与未来展望
Endocr Oncol. 2024 Dec 19;4(1):e240055. doi: 10.1530/EO-24-0055. eCollection 2024 Jan 1.
6
Characterization of Epithelial-Mesenchymal and Neuroendocrine Differentiation States in Pancreatic and Small Cell Ovarian Tumor Cells and Their Modulation by TGF-β1 and BMP-7.胰腺和小细胞卵巢肿瘤细胞上皮-间质及神经内分泌分化状态的特征及其受转化生长因子-β1和骨形态发生蛋白-7的调控
Cells. 2024 Dec 5;13(23):2010. doi: 10.3390/cells13232010.
7
Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.通过表观遗传机制,胃肠胰神经内分泌肿瘤中钙敏感受体的表达下调。
Int J Cancer. 2025 Mar 1;156(5):980-992. doi: 10.1002/ijc.35264. Epub 2024 Nov 23.
8
FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.FOXA2 启动的甲基丙二酸诱导的 INHBA 转录激活促进胰腺神经内分泌肿瘤进展。
Cell Mol Life Sci. 2024 Jan 22;81(1):50. doi: 10.1007/s00018-023-05084-0.
9
Examination of the mechanism of Piezo ion channel in 5-HT synthesis in the enterochromaffin cell and its association with gut motility.研究 Piezo 离子通道在肠嗜铬细胞 5-HT 合成中的作用机制及其与肠道动力的关系。
Front Endocrinol (Lausanne). 2023 Nov 2;14:1193556. doi: 10.3389/fendo.2023.1193556. eCollection 2023.
10
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.胰腺神经内分泌肿瘤的模型:当前观点与未来方向
Cancers (Basel). 2023 Jul 25;15(15):3756. doi: 10.3390/cancers15153756.
一组 microRNAs 协同控制肿瘤发生、侵袭和转移。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24184-24195. doi: 10.1073/pnas.1913307116. Epub 2019 Nov 8.
4
MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.miR-3653 通过靶向 Zeb2 抑制结肠癌的转移和上皮-间充质转化。
Pathol Res Pract. 2019 Oct;215(10):152577. doi: 10.1016/j.prp.2019.152577. Epub 2019 Aug 2.
5
Reduced expression of miR-3653 in glioma and its correlations with clinical progression and patient survival.miR-3653 在脑胶质瘤中的表达降低及其与临床进展和患者生存的相关性。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6596-6601. doi: 10.26355/eurrev_201908_18547.
6
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.增强子特征可对无功能胰腺神经内分泌肿瘤的结局进行分层和预测。
Nat Med. 2019 Aug;25(8):1260-1265. doi: 10.1038/s41591-019-0493-4. Epub 2019 Jul 1.
7
miR-17-92 and miR-106b-25 clusters regulate beta cell mitotic checkpoint and insulin secretion in mice.miR-17-92 和 miR-106b-25 簇调节小鼠β细胞有丝分裂检查点和胰岛素分泌。
Diabetologia. 2019 Sep;62(9):1653-1666. doi: 10.1007/s00125-019-4916-z. Epub 2019 Jun 11.
8
ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.ALK7 信号表现出一种组织稳态的屏障,在肿瘤发生和转移过程中被破坏。
Dev Cell. 2019 May 6;49(3):409-424.e6. doi: 10.1016/j.devcel.2019.04.015.
9
MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.miRNA-3653 是胰腺神经内分泌肿瘤转移风险增加的潜在组织生物标志物。
Endocr Pathol. 2019 Jun;30(2):128-133. doi: 10.1007/s12022-019-9570-y.
10
Insight into miRNAs related with glucometabolic disorder.对与糖代谢紊乱相关的 miRNA 的深入了解。
Biomed Pharmacother. 2019 Mar;111:657-665. doi: 10.1016/j.biopha.2018.12.123. Epub 2019 Jan 3.